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Background
Close to half of the human genome is derived from trans-
posable elements (TEs), and some TE families continue
to generate new insertions through RNA-mediated
mechanisms. Due to its mutagenic potential, such retro-
transposition is normally suppressed by epigenetic and
post-transcriptional mechanisms. However, the epige-
netic and regulatory disruptions commonly observed in
cancers may allow for TE activation, and a few examples
have been reported in lung and colon cancer previously.
Materials and methods
To systematically evaluate the frequency of such events
across different tumor types and assess their impact in
human cancers, we developed Tea (Transposable element
analyzer), a computational pipeline to detect TE insertions
at single nucleotide level and extract their mechanistic sig-
natures. We applied Tea to the high-coverage (>30×)
tumor and matched normal genome pairs from 43 cancer
patients across five tumor types as well as three healthy
individuals.
Results
We identified 194 high-confidence somatic TE insertions
(183 L1, 10 Alu, 1 ERV), most of which were generated
through endonuclease-mediated retrotransposition
mechanism. The novel L1 and Alu insertions were all
found in the epithelial cancers (colorectal, prostate, ovar-
ian), and none were detected in the examined blood or
brain tumor samples. The somatic L1 insertions tend to
occur in genes that are commonly mutated in cancer, and
disrupt the expression of the targeted genes. To further
illustrate the distinct genomic distribution of the somatic
TE landing sites, we compared their placement with the
7,449 non-reference polymorphic TE insertions that we
have identified from 44 normal genomes. The TE landing
sites are strongly biased towards genomic regions that
exhibit cancer-specific decrease in DNA methylation.
Conclusions
Our analysis illustrates the functional impact of somatic
TE insertions and suggests resulting positive selection
toward tumorigenesis.
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